Skip to main content
THERACRYF PLC logo

THERACRYF PLC — Investor Relations & Filings

Ticker · TCF ISIN · GB00BSVYN304 LEI · 213800NO3E6TSTQO8K20 IL Professional, scientific and technical activities
Open in API
Filings indexed 361 across all filing types
Latest filing 2025-10-16 Major Shareholding Noti…
Country GB United Kingdom
Listing IL TCF

About THERACRYF PLC

https://theracryf.com/

TheraCryf PLC is a clinical-stage therapeutics company focused on developing a new generation of innovative medicines for behavioural brain disorders and oncology. The company's research and development efforts are centered on sulforaphane-based compounds. Its primary therapeutic focus is on conditions such as opioid and alcohol abuse, binge eating disorder, anxiety, and fatigue. TheraCryf's business strategy is to generate compelling clinical data for its drug candidates with the goal of partnering its programs with larger pharmaceutical companies for late-stage development and commercialization.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by Theracryf PLC. This form is specifically used to report changes in significant share ownership (crossing thresholds) as required by regulatory authorities (FCA/DTR). This aligns perfectly with the definition of a Major Shareholding Notification.
2025-10-16 English
World Mental Health Day & Q4 Conference Schedule
Regulatory Filings Classification · 100% confidence The document is a press release distributed via the RNS Reach service. It provides a corporate update regarding World Mental Health Day and lists the company's upcoming conference schedule for Q4 2025. It does not contain financial results, regulatory filings, or specific corporate actions that fit into other categories. As it is a general corporate announcement/press release, it falls under the fallback category of Regulatory Filings (RNS).
2025-10-10 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by Spreadex LTD regarding their interest in Theracryf PLC. This is a regulatory requirement for shareholders to disclose when their voting rights cross specific thresholds. This fits the definition of a Major Shareholding Notification (MRQ).
2025-09-26 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings' filed by Spreadex LTD regarding their interest in Theracryf PLC. This is a classic regulatory disclosure form used in the UK to notify the market when a shareholder crosses a specific voting rights threshold. This fits the definition of a Major Shareholding Notification (MRQ).
2025-09-08 English
Ox-1 Patent Grant & Development Programme Update
Regulatory Filings Classification · 100% confidence The document is an RNS (Regulatory News Service) announcement from TheraCryf PLC regarding a patent grant and a development program update for its Ox-1 drug. It does not fit into specific categories like financial reports, dividend notices, or board changes. As it is a general regulatory announcement regarding company operations and progress, it falls under the 'Regulatory Filings' category.
2025-09-04 English
Group of companies' accounts made up to 2025-03-31
Regulatory Filings
2025-08-29 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.